Chi‐Yen Chang
National Health Research Institutes(TW)
Publications by Year
Research Areas
Synthesis and biological activity, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Cancer therapeutics and mechanisms, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Oxygen- and Growth Rate-Dependent Regulation of Escherichia coli Fumarase (FumA, FumB, and FumC) Activity(2001)98 cited
- → History and dietary husbandry of pangolins in captivity(2007)93 cited
- → Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Anticancer Activity(2009)62 cited
- → Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents(2011)34 cited
- → Synthesis and Structure−Activity Relationships of 2-Amino-1-aroylnaphthalene and 2-Hydroxy-1-aroylnaphthalenes as Potent Antitubulin Agents(2008)31 cited
- → Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91(2009)22 cited
- → BPR0C261 is a novel orally active antitumor agent with antimitotic and anti‐angiogenic activities(2010)13 cited
- → Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents(2014)11 cited
- → Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan(2024)8 cited
- → Abstract 4461: MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA(2011)2 cited